학술논문

O-005 - Treating HER2-mutant advanced biliary tract cancer with neratinib: benefits of HER2-directed targeted therapy in the phase 2 SUMMIT 'basket' trial.
Document Type
Article
Source
Annals of Oncology. 2019 Supplement, Vol. 30, piv127-iv127. 1p.
Subject
*BASKETS
BILIARY tract cancer
Language
ISSN
0923-7534